I
ISSUER//CIK 0001518520
Icagen, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 10-Q13.3 MBIcagen, Inc.Feb 19, 6:16 AM ET·0001213900-20-004183
- 8-K377.8 KBIcagen, Inc.Aug 30, 4:56 PM ET·0001213900-19-017040
- 10-Q5.4 MBIcagen, Inc.Aug 19, 5:29 PM ET·0001213900-19-016342
- 10-Q5.2 MBIcagen, Inc.May 15, 2:12 PM ET·0001213900-19-008759
- 8-K753.4 KBIcagen, Inc.May 2, 4:06 PM ET·0001213900-19-007698
- 10-K8.8 MBIcagen, Inc.Apr 12, 4:02 PM ET·0001213900-19-006256
- SC 13D/A59.5 KBIcagen, Inc.Jan 11, 7:01 AM ET·0001213900-19-000556
- 8-K42.2 KBIcagen, Inc.Nov 20, 5:03 PM ET·0001213900-18-016316
- 10-Q6.4 MBIcagen, Inc.Nov 19, 3:57 PM ET·0001213900-18-016174
- 8-K/A6.9 MBIcagen, Inc.Oct 1, 3:46 PM ET·0001213900-18-013278
Insiders
9Tickers
No tickers on record
Addresses
business
4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK
DURHAM, NC, 27703
mailing
4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK
DURHAM, NC, 27703
Former Names
- XRpro Sciences, Inc.2015-08-14
- Caldera Pharmaceuticals Inc2014-11-25